# Identifying Prognostic Variables for Persistent UL Dysfunctions After Breast Cancer Treatment -Reliability and Validity

> **NCT05371847** · NA · UNKNOWN · sponsor: **KU Leuven** · enrollment: 150 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **OTHER:** assessment for upper limb dysfunction
- **OTHER:** retest assessment

## Key facts

- **NCT ID:** NCT05371847
- **Lead sponsor:** KU Leuven
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-04-26
- **Primary completion:** 2025-02
- **Final completion:** 2025-02
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2024-05-01

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05371847

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05371847, "Identifying Prognostic Variables for Persistent UL Dysfunctions After Breast Cancer Treatment -Reliability and Validity". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05371847. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*